Chemed
500 hedge funds and large institutions have $8.66B invested in Chemed in 2023 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 171 increasing their positions, 172 reducing their positions, and 30 closing their positions.
316% more call options, than puts
Call options by funds: $6.08M | Put options by funds: $1.46M
173% more first-time investments, than exits
New positions opened: 82 | Existing positions closed: 30
16% more capital invested
Capital invested by funds: $7.46B → $8.66B (+$1.21B)
10% more funds holding
Funds holding: 456 → 500 (+44)
3.34% more ownership
Funds ownership: 95.04% → 98.38% (+3.3%)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
1% less repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 172
Top Buyers
Top Sellers
CHE Hedge Fund Activity: Q4 2023 in Review
500 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Chemed (CHE) for Q4 2023, worth a combined $8.66B — up 16% from $7.46B a quarter earlier.
Buyers outnumbered sellers: 82 funds opened new CHE positions and 30 closed out — a net gain of 52 holders — while 171 added to existing stakes and 172 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $234M. The largest seller was Wellington Management Group, cutting an estimated $86M.
- 500 institutional investors held Chemed (CHE) as of Q4 2023, up from 456 in Q3 2023.
- Funds reported $8.66B of Chemed stock for Q4 2023, up 16% quarter-over-quarter.
- 82 funds opened new Chemed positions in Q4 2023 and 30 closed out, a net change of +52 holders.
- The largest Chemed buyer in Q4 2023 was Morgan Stanley, an estimated $234M added.
- The largest Chemed seller in Q4 2023 was Wellington Management Group, an estimated $86M sold.
Based on aggregated 13F filings for Q4 2023.